Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 11 studies | 23% ± 7% | |
endothelial cell | 6 studies | 23% ± 5% | |
glutamatergic neuron | 5 studies | 40% ± 21% | |
natural killer cell | 5 studies | 19% ± 3% | |
macrophage | 5 studies | 20% ± 3% | |
epithelial cell | 4 studies | 34% ± 8% | |
fibroblast | 4 studies | 18% ± 2% | |
type I pneumocyte | 4 studies | 18% ± 2% | |
GABAergic neuron | 4 studies | 39% ± 16% | |
non-classical monocyte | 3 studies | 19% ± 5% | |
astrocyte | 3 studies | 23% ± 5% | |
CD8-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
dendritic cell | 3 studies | 28% ± 8% | |
basal cell | 3 studies | 21% ± 1% | |
transit amplifying cell | 3 studies | 21% ± 6% | |
interneuron | 3 studies | 34% ± 17% | |
neuron | 3 studies | 32% ± 5% | |
oligodendrocyte | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1221.31 | 1445 / 1445 | 100% | 10.12 | 183 / 183 |
intestine | 100% | 1156.41 | 966 / 966 | 100% | 10.46 | 527 / 527 |
skin | 100% | 1196.84 | 1809 / 1809 | 100% | 15.08 | 472 / 472 |
uterus | 100% | 1205.65 | 170 / 170 | 100% | 20.65 | 459 / 459 |
brain | 100% | 824.55 | 2638 / 2642 | 100% | 14.42 | 705 / 705 |
lung | 100% | 1166.87 | 577 / 578 | 100% | 16.90 | 1155 / 1155 |
bladder | 100% | 1156.67 | 21 / 21 | 100% | 16.38 | 503 / 504 |
prostate | 100% | 962.52 | 245 / 245 | 100% | 10.02 | 501 / 502 |
ovary | 100% | 1256.28 | 180 / 180 | 100% | 12.15 | 429 / 430 |
breast | 100% | 1242.41 | 459 / 459 | 100% | 13.99 | 1115 / 1118 |
thymus | 100% | 935.78 | 653 / 653 | 99% | 14.43 | 601 / 605 |
stomach | 100% | 868.70 | 359 / 359 | 99% | 9.86 | 284 / 286 |
pancreas | 100% | 654.92 | 327 / 328 | 99% | 12.20 | 177 / 178 |
adrenal gland | 100% | 893.59 | 258 / 258 | 96% | 6.89 | 220 / 230 |
kidney | 100% | 892.61 | 89 / 89 | 95% | 11.91 | 856 / 901 |
liver | 99% | 406.84 | 224 / 226 | 96% | 7.65 | 389 / 406 |
adipose | 100% | 1195.96 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1077.73 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.85 | 29 / 29 |
spleen | 100% | 1317.22 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.01 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 24.00 | 1 / 1 |
heart | 99% | 635.90 | 854 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 538.50 | 796 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 10.62 | 79 / 80 |
peripheral blood | 97% | 833.47 | 900 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001514 | Biological process | selenocysteine incorporation |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000049 | Molecular function | tRNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | TRNAU1AP |
Protein name | tRNA selenocysteine 1-associated protein 1 (SECp43) (tRNA selenocysteine-associated protein 1) |
Synonyms | SECP43 TRSPAP1 |
Description | FUNCTION: Involved in the early steps of selenocysteine biosynthesis and tRNA(Sec) charging to the later steps resulting in the cotranslational incorporation of selenocysteine into selenoproteins. Stabilizes the SECISBP2, EEFSEC and tRNA(Sec) complex. May be involved in the methylation of tRNA(Sec). Enhances efficiency of selenoproteins synthesis (By similarity). . |
Accessions | ENST00000373830.4 [Q9NX07-1] Q9NX07 |